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OAG-stimulated superoxide (05) production by HL-60 granulocytes howed enantiomeric specificity but 
reached a maximum of only 5% of that produced by either phorbol myristate acetate (PMA) or phorbol 
dibutyrate (PDBu). At 10-100 ,uM, OAG displaced specifically-bound [3H]PDBu from intact HL-60 cells 
by only 25%, suggesting limited cell penetration. OAG (l&100 ,uM) also inhibited PDBu-stimulated 05 pro- 
duction by 25%; this inhibition was enantiomerically specific. However, at a lower concentration (3 PM), 
both enantiomers of OAG fully blocked 02 production stimulated by PMA (0.5 PM). This inhibition is 
probably artefactual, due to the hydrophobic PMA physically associating with OAG in the extracellular 
fluid. 
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1. INTRODUCTION 
The phospholipid- and calcium-dependent pro- 
tein kinase C (PKC) is now recognised as playing 
a key role in the transduction of signals generated 
by many agonist-receptor interactions [ 11, being 
activated by diacylglycerol generated in the plasma 
membrane from phosphatidylinositol-4,5 bis- 
phosphate breakdown [2]. In addition phorbol 
esters, which bear structural relationships to 
diacylglycerols, also bind to and activate the kinase 
[3]. Activation of PKC has been implicated in 
many diverse physiological responses including 
stimulation of degranulation and the oxidative 
burst by polymorphonuclear leukocytes [4,5]. 
We have used a model neutrophil system, 
dimethyl sulphoxide-differentiated HL-60 cells, to 
study activation of PKC by phorbol esters and 
diacylglycerols [6,7]. The generation of superoxide 
(0;) by HL-60 granulocytes is stimulated 
dramatically by phorbol esters [a]. Unlike a 
number of other responses, such as degranulation, 
02 production appears to be independent of 
changes in cytosolic calcium [8]. Generation of 02 
thus provides a convenient and direct functional 
measurement of PKC activation. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
HL-60 promyelocytes were grown as suspension 
cultures in RPMI-1640 medium (Gibco), sup- 
plemented with 15 070 (v/v) heat-inactivated foetal 
calf serum (low endotoxin, Gibco) and a further 
2 mM L-glutamine (Flow Laboratories). Cells 
were seeded at a density of 0.25 x 106/ml and sub- 
cultured twice weekly by resuspending in fresh 
medium so that their density did not exceed 2 x 
106/ml. Cells were induced to differentiate along 
recognisable myeloid lines by the addition of 
dimethyl sulphoxide to a final concentration of 
1.3% (v/v) and were used between 6 and 9 days 
later. 
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2.2. Superoxide measurement 2.4. Isolation of protein kinase-C 
Superoxide anion production by the NADPH- 
dependent oxidase was measured as the reduction 
of ferricytochrome-c by a modification of the 
method of Cohen and Chovaniec [9]. HL-60 
granulocytes were washed twice and resuspended 
at 0.3 x 106/ml in Hanks’ balanced salt solution 
buffered with 30 mM Hepes (pH 7.4) and gassed 
with 02 before use. Cells (1 ml) were added to 
plastic cuvettes containing 1 ml of 15OpM 
ferricytochrome-c (Sigma, Horse Heart type VI) 
dissolved in Hanks’ solution. Samples were 
warmed for 5 min at 37°C before being placed in 
a spectrophotometer (Pye Unicam SP1750) 
equipped with an automatic cell changer warmed to 
37°C. Extinction at 550 nm was measured against 
air, changes being recorded continuously for either 
15 or 20 min after adding the PKC activator. The 
amount of 02 produced was calculated from the 
change in absorbance; 6 = 21000 M-‘*cm-’ 
(reduced minus oxidised forms). Changes in ex- 
tinction could be abolished by the addition of 
superoxide dismutase (75 units, bovine erythro- 
cyte, from Sigma) before cell activation. 
Diacylglycerols and phorbol esters were added in 
2 ~1 of ethanolic solution to 2 ml of cell 
suspension. 
PKC was isolated from rat brain cytosol using 
the procedure of Niedel et al. [lo] and its activity 
measured using the Triton X-100 mixed-micelle 
method described by Hannun et al. [l 11. The en- 
zyme preparation was characterised as containing 
PKC by virtue of histone-phosphorylating activity 
which was dependent on Ca2+ and phos- 
phatidylserine and stimulated 8-l 5-fold by addi- 
tion of 1,2-dihexanoyl-sn-glycerol (5 mol%), 
activation being specific for the 1,2-sn-enantiomer. 
2.5. Synthesis of diacyiglycerols 
1-Oleoyl-2-acetyl-sn-glycerol was prepared 
essentially by the method of Mori et al. [12] 
starting from I-oleoyl-sn-glycerol. The previously 
unreported 3-oleoyl-2-acetyl-sn-glycerol was pre- 
pared in an analogous manner starting from 
3-oleoyl-sn-glycerol. Both products were shown to 
be free of 1,3-isomers by thin-layer chroma- 
tography and nuclear-magnetic resonance spec- 
troscopy. 
2.6. Preparation of solutions 
2.3. tH]Phorbol dibutyrate @HJPDBu) binding 
Undifferentiated HL-60 cells were taken in the 
log phase of growth, washed twice and resuspend- 
ed in Hepes-buffered Hanks’ solution, as before. 
The binding assay was carried out in 
polypropylene tubes at 37”C, the assay mix (1 ml) 
containing 2.5 x lo6 cells, 10 nM [3H]PDBu 
(14-20 ,uCi/nmol) and diacylglycerol or unlabelled 
PDBu, as indicated in the text. The cell suspension 
was preincubated at 37°C for 12 min before addi- 
tions were made, each being in 1 pl volume of 
ethanolic solution: 17 min later, 0.75 ml of the 
assay mixture was removed and filtered through a 
Whatman GF/C filter which was then washed 3 
times with 4 ml of Hanks’ solution at 4°C. Tritium 
associated with the filters was determined by 
dispersing them in 5 ml scintillant (Picofluor) and 
counting in a Beckman scintillation counter. Non- 
specific binding is defined as that observed in the 
presence of lOOO-fold excess of unlabelled PDBu. 
Phorbol esters (Sigma) were stored as solutions 
(1 mg/ml) in acetone at -20°C. For use, the 
acetone was evaporated and the compound 
redissolved in ethanol (Fisons, Spectrograde) at 
lOOO-times the required final concentration. 
Diacylglycerols were stored at -20°C until use 
when they were also dissolved in ethanol at 
lOOO-times the final concentration. 
3. RESULTS AND DISCUSSION 
OAG stimulated 02 production by HL-60 
granulocytes in an enantiomerically specific man- 
ner (fig.1). The response to the synthetic 
diacylglycerol was small when compared with a 
known activator of 0: production in HL-60 cells, 
the chemotactic peptide, formyl-methionyl-leucyl- 
phenylalanine (fMLP). However, combining the 
peptide with OAG produced a synergistic interac- 
tion which also displayed stereospecificity (fig. 1). 
The phorbol esters PMA and PDBu are potent 
stimulators of 01 production in HL-60 
granulocytes [6]. Fig.2 shows the dose-response 
curves for PMA, PDBu and OAG in these cells. 
The EDso values for PMA and PDBu were 4.0 x 
10-r’ M and 6.3 x 10-s M, respectively. PMA was 
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Fig. 1. Superoxide production by HL-60 granulocytes. 
Synergistic interaction between OAG and the 
chemotactic peptide fMLP. F, FMLP (1 PM); A, 
1-oleoyl-2-acetyl-sn-glycerol (100 pM); B, 3-oleoyl- 
2-acetyl-sn-glycerol (100 PM). Results are the means 
( f SE) of 4-l 1 individual determinations. 
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Fig.2. Diacylglycerol- and phorbol ester-stimulated 0% 
production by HL-60 granulocytes. Each point 
represents the mean (f SE) of 6 separate deter- 
minations. Maximum PMA response = 168 nmol 
02/106 cells in 20 min. 
therefore approximately loo-times more potent 
than PDBu as a stimulus for 02 production; 
nevertheless both agents generated the same max- 
imum response. In contrast, OAG produced only 
5% of the maximum response elicited by the phor- 
bol esters (fig.2). 
Activation by OAG of partially purified PKC 
reached the same maximum as that induced by the 
phorbol esters (not shown). This contrasts sharply 
with the ability of OAG to stimulate 02 produc- 
tion (fig.2). Possible explanations are either that 
OAG is unable to penetrate to the sites on PKC 
that are accessible to phorbol esters in intact cells, 
or that the effective concentration of OAG is 
diminished through metabolism, as occurs in 
platelets [13]. The interpretation of restricted ac- 
cess was reinforced by the observation that OAG 
displaced specifically-bound [3H]PDBu from in- 
tact HL-60 cells by a maximum of only 25% 
(fig.3). 
An alternative explanation for these different 
maxima might have been that OAG is a partial 
agonist at the phorbol ester site on PKC. Although 
this clearly was not the case for the enzyme isolated 
from rat brain, it is conceivable that the PKC of 
HL-60 cells has an activation profile different 
from that of the brain enzyme. If OAG was a par- 
tial agonist at the phorbol ester site it should, by 
definition, competitively antagonise responses 
mediated by full agonists [14]. The action of OAG 
on either PDBu- or PMA-induced 02 production 
is shown in fig.4. OAG inhibited PDBu-stimulated 
02 production by 25% and this effect was enan- 
tiomerically specific. The small degree of inhibi- 
tion of the PDBu response by OAG is in agreement 
with the poor displacement of [3H]PDBu from in- 
tact cells, suggesting perhaps that the inhibitory ac- 
tion of OAG is limited by its accessibility to the 
PDBu site on PKC. 
In contrast to the PDBu response, PMA induced 
0; production was completely inhibited by OAG 
at a concentration of 3 /rM (fig.4). Furthermore, 
the inhibitory action of OAG was not enan- 
tiomerically specific. This lack of stereospecificity 
implies that the effect of OAG against PMA- 
OL 1 
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Fig.3. Displacement of [3H]PDBu from HL-60 cells by 
PDBu and OAG. Each point represents the mean ( f SE) 
of 9 separate observations. 
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Fig.4. Inhibition of PMA (0.5 nM, l )- and PDBu 
(100 nM, n )-stimulated 0s production by OAG. (A) 
l-Oleoyl-2-acetyl-sn-glycerol; (B) 2-acetyl-3-oleoyl-.sn- 
glycerol. Each point represents the mean (& SE) of 3-5 
separate experiments each in triplicate. 
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Fig.5. Effect of OAG on the distribution of [‘HIPMA 
between HL-60 cells and the supernatant. Each value 
represents the mean (+ SD) of 4 separate 
determinations. (A) l-Oleoyl-2-acetyl-sn-glycerol; (B) 
3-oleoyl-2-acetyl-sn-glycerol. 
induced responses is artefactual. The partition 
coefficients of PMA and PDBu differ by a factor 
of 104. Therefore, the extremely hydrophobic 
nature of PMA compared with PDBu may result in 
a physical association with OAG in the aqueous 
phase, particularly if the concentration of OAG is 
close to its critical micellar concentration. Consis- 
tent with this was the observation that OAG 
decreased the association of [3H]PMA with the cell 
pellet and increased the amount of [3H]PMA 
associated with the supernatant fraction (fig.5). As 
would be expected, this effect was not enan- 
tiomerically specific. Thus, a large part of the in- 
hibitory action of OAG may be attributed to the 
ability of OAG to lower the concentration of PMA 
in HL-60 cells. This artefact would affect 
responses to PDBu to a lesser, possibly insignifi- 
cant, degree because PDBu is much less 
hydrophobic than PMA. 
From the above analysis, the inhibition by OAG 
of other PMA-induced responses, such as 
degranulation in human neutrophils (reported by 
O’Flaherty et al. [15]), can be explained as being 
artefactual. Clearly, studies which are designed to 
measure the inhibition of PKC-mediated responses 
must eliminate artefactual hydrophobic interac- 
tions, and we believe that the use of PDBu rather 
than PMA as an activator will reduce this possibili- 
ty. Thus, the small but enantiomerically specific 
inhibition of PDBu-stimulated 02 production is 
probably not an artefact. The mechanism by which 
this inhibition occurs will be the subject of further 
investigation. 
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